AbbVie Stock Will $300: Timing and Risks to Watch
AbbVie’s Q1 2026 results show strong immunology growth even as biosimilar challenges weigh on revenue. Analysts debat...
Assess tax efficiency between S&P 500 ETFs and index funds for retirement, focusing on taxes, distributions, and long-term strategy.
27,886 articlesAbbVie’s Q1 2026 results show strong immunology growth even as biosimilar challenges weigh on revenue. Analysts debat...
Sarah Jessica Parker’s journey from a large, struggling family to a $200 million fortune highlights how grit and ambi...
A brief but frightening liquidity scare exposed vulnerabilities in the financial system. Regulators acted fast to con...
Hon Hai Precision posts a 40% quarterly jump, powered by AI server demand. The result highlights ongoing AI spending ...
Jim Cramer argues that Google could win the AI war by leveraging Apple’s massive device base, a move that could redef...
A New Jersey homeowner filed a lawsuit against Newrez LLC (Shellpoint Mortgage Servicing), accusing years of improper...
Synopsys is set to report its fiscal Q1 results after the bell today. Traders will watch for IP-unit performance and ...
XRP is mired in a short-term pullback as buyers hesitate near $1.40. With two red weekly candles, analysts flag a pot...
Rivian’s shares fell roughly 5% after unveiling the R2, erasing prior gains as the market assesses the mass-market pr...
A March 17, 2026 report from Muddy Waters Research targets SoFi Technologies, spurring volatility as KBW weighs in. S...
Federal health officials issued a warning about misleading statements from biotech billionaire Patrick Soon-Shiong re...
A ransomware attack on Canvas disrupted finals across thousands of schools as the ShinyHunters group claimed responsi...